Assessment of symptom burden and quality of life in patients with primary brain tumors receiving palliative care in a tertiary cancer care centre

Author:

Padhi Pratyasa1,Gupta Nishkarsh1,Bharati Sachidanand Jee1,Garg Rakesh1,Mishra Seema1,Bhatnagar Sushma1,KP Haresh1,Kumar Vinod1

Affiliation:

1. Dr BRA IRCH AIIMS

Abstract

Abstract

Background Primary brain tumor patients present with a unique trajectory of illness, with an uncertain prognosis, a rapid decline in physical functioning and a significant worsening of quality of life. Methods The EORTC QLQ C30 & EORTC BN 20 questionnaires were used to assess quality of life and symptom burden in patients with primary brain tumors. The scores were analysed using SPSS statistical software. Results One hundred patients—61 males and 39 females—with radiological or histo-pathological diagnoses of primary brain tumors were included. Seizures (38%) were the most common presenting symptom (38%), followed by headache (18%), loss of consciousness (13%), focal neurological deficit (9%) and blurring of vision (8%). The mean quality of life at baseline was 78.29, with a standard deviation of 9.67 on a scale of 0 to 100, and the brain tumor-specific symptom burden score was 46.9, with a standard deviation of 17.95 on a scale of 0 to 100. There was a significant difference in the global health status score between the first visit and third visit, i.e., at three months (p value = 0.03). Conclusion Primary brain tumors are often aggressive and deemed incurable. Unaddressed symptoms such as fatigue and insomnia, future uncertainties and decreased social functioning are widely prevalent in such patients. The integration of palliative care in the treatment course is important to ensure good quality of life in such patients.

Publisher

Springer Science and Business Media LLC

Reference12 articles.

1. Cancer [Internet].[cited2023Jul18].Availablefrom:https://www.who.int/health-topics/cancer#tab=tab_1

2. The growing burden of cancer in India: epidemiology and social context;Mallath MK;Lancet Oncol,2014

3. Brain tumours: incidence, survival, and aetiology;McKinney P;J Neurol Neurosurg Psychiatry.2004Jun

4. A randomized trial of bevacizumab for newly diagnosed glioblastoma;Gilbert MR;N Engl J Med,2014

5. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors;Armstrong TS;J Nurs Scholarsh,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3